Lei Li
Academic / Other · 61 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence Ovarian Cancer | — | 2024-10-01 |
| Not Yet Recruiting | Cervical Cytology DNA Methylation for Cervical Cancer Screening Cervical Cancer, DNA Methylation, Cytology | — | 2024-09-01 |
| Not Yet Recruiting | A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening Uterine Cervical Cancer, Cervical Intraepithelial Neoplasia, High Grade Squamous Intraepithelial Lesions | N/A | 2024-08-01 |
| Not Yet Recruiting | A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection Uterine Cervical Cancer, High Grade Squamous Intraepithelial Lesions, Low Grade Squamous Intraepithelial Lesions | — | 2024-07-01 |
| Unknown | ctDNA Methylation for Detecting Ovarian Cancer Epithelial Ovarian Cancer, Circulating Tumor DNA, DNA Methylation | — | 2023-03-24 |
| Unknown | ctDNA Methylation for Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Circulating Tumor DNA, DNA Methylation | — | 2023-03-24 |
| Completed | HRD Status Reference Standard Based on WGS Ovarian Cancer | — | 2022-12-30 |
| Unknown | Niraparib Plus Anlotinib for Recurrent Ovarian Cancer Ovarian Carcinoma, Survival Outcomes, Adverse Events | Phase 2 | 2022-03-27 |
| Unknown | Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma | Phase 2 | 2022-03-27 |
| Unknown | Tislelizumab and Radiotherapy for Recurrent Cervical Cancer Recurrent Cervical Carcinoma, Metastatic Cervical Carcinoma, Persistent Cervical Carcinoma | Phase 2 | 2022-03-27 |
| Unknown | PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer Cervical Carcinoma, Chemoradiotherapy, Anti-programmed Cell Death Receptor 1 | Phase 2 | 2022-03-27 |
| Unknown | Donafenib for Recurrent Cervical Cancer Targeted Therapy, Chemotherapy, Recurrent Cervical Carcinoma | Phase 2 | 2022-03-27 |
| Unknown | HRD and Resistance to PAPPi in EOC Patients Epithelial Ovarian Cancer, Homologous Recombination Deficiency, Homologous Recombination Repair Gene Mutation | — | 2022-03-26 |
| Unknown | Prognosis of Low-grade Endometrial Stromal Sarcoma Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis), Fertility-sparing Surgery, Survival Outcomes | — | 2022-03-26 |
| Unknown | Chromosomal Instability in Ovarian Cancer Epithelial Ovarian Cancer, High-grade Serous Ovarian Carcinoma, Chromosomal Instability | — | 2022-03-26 |
| Unknown | PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer Immune Checkpoint Inhibitors, Anti-programmed Death-1 Antibody, Radiotherapy | — | 2022-03-26 |
| Unknown | Cervical Cancer Screening Strategies Cervical Cancer, Cervical Intraepithelial Neoplasia, Human Papillomavirus Infection | — | 2022-03-19 |
| Unknown | Host DNA Methylation for Endometrial Cancer Screening Cancer Screening, Endometrial Cancer, DNA Methylation | — | 2022-03-13 |
| Unknown | Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemotherapy | Phase 2 | 2022-03-13 |
| Unknown | DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening Endometrial Cancer, Cancer Screening, DNA Methylation | — | 2022-03-12 |
| Unknown | Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma Recurrent Cervical Carcinoma, Radiotherapy, Epidermal Growth Factor Receptor | Phase 2 | 2020-12-19 |
| Unknown | Cell-free DNA Methylation for Endometrial Cancer Endometrial Cancer, Liquid Biopsy, DNA Methylation | N/A | 2020-12-18 |
| Unknown | Immunohistochemical Staining of p16 for the Screening of Cervical Cancer Cervical Cancer Screening, p16 Protein, Cytology | Phase 2 | 2020-11-26 |
| Unknown | A Training Set for the HRD Model in EOC Epithelial Ovarian Cancer, BRCA Mutation, Loss of Heterozygosity | — | 2020-11-26 |
| Unknown | DNA Methylation Testing for the Screening of Uterine Cervical Lesion Cervical Cancer, Cervical Intraepithelial Neoplasia, DNA Methylation | Phase 3 | 2020-11-26 |
| Unknown | Cell-free DNA Methylation for Epithelial Ovarian Cancer Epithelial Ovarian Cancer, DNA Methylation, Benign Ovarian Tumor | Phase 2 | 2020-11-26 |
| Completed | A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Chinese, Homologous Recombination Deficiency | — | 2020-11-26 |
| Unknown | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas Chemotherapy, Anti-pd-1 Antibody, Cervical Neuroendocrine Carcinoma | Phase 2 | 2020-11-15 |
| Unknown | National Survey of the Impact of COVID-19 Pandemics COVID-19 Pandemics, Obstetrics and Gynecology, Workload | — | 2020-07-27 |
| Unknown | National Survey of Workplace Violence Workplace Violence Against Physicians, National Survey, Obstetrics and Gynecology | — | 2020-07-27 |
| Unknown | Genetic Mutation in Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Nucleotide Variant, Copy Number Variation | — | 2019-12-19 |
| Unknown | Genetic Mutation in Recurrent Cervical Cancer Recurrent Cervical Cancer, Nucleotide Variant, Copy Number Variation | — | 2019-12-19 |
| Unknown | Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Chinese, Homologous Recombination Deficiency | — | 2019-12-07 |
| Completed | First-line Chemotherapy for Recurrent Cervical Cancer Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemotherapy | Phase 2 | 2019-12-06 |
| Completed | Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemotherapy | Phase 2 | 2019-12-06 |
| Unknown | Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Canc Chemotherapy-induced Neutropenia, Febrile Neutropenia, Drug-Induced, Epithelial Ovarian Cancer | Phase 3 | 2019-10-01 |
| Unknown | Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis Adenomyosis, Endometrial Cancer, Ectopic Endometrial Tissue | — | 2019-07-16 |
| Unknown | Comprehensive Study on the Quality of Life in Cervical Cancer Patients Quality of Life, Cervical Cancer, Urodynamics | — | 2019-06-19 |
| Unknown | NAC Followed by RH for the Treatment of LACC Neoadjuvant Chemotherapy, Locally Advanced Cervical Cancer, Radical Hysterectomy | Phase 2 | 2019-06-19 |
| Unknown | A Cohort Study for the Following up of Conization Precancerous Lesions, Conization, High Grade Intraepithelial Neoplasia | — | 2019-06-03 |
| Unknown | DNA Methylation for Screening Uterine Cervical Lesions DNA Methylation, Uterine Cervical Cancer, High Grade Squamous Intraepithelial Lesions | — | 2019-06-01 |
| Unknown | DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study DNA Methylation, Uterine Cervical Cancer, High Grade Squamous Intraepithelial Lesions | — | 2019-05-22 |
| Unknown | Immune Repertoire of Ovarian HGSC Ovarian High Grade Serous Carcinoma, Immune Repertoire, T Lymphocyte Receptor | — | 2019-01-03 |
| Unknown | G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients Gynecologic Cancer, Myelosuppression Adult, Febrile Neutropenia | Phase 4 | 2019-01-03 |
| Unknown | Different Surgical Approaches in Patients of Early-stage Cervical Cancer Uterine Cervical Neoplasm, Laparotomy, Laparoscopy | Phase 3 | 2018-11-23 |
| Unknown | Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline Gynecologic Cancer, Chemotherapy-induced Nausea and Vomiting | — | 2018-11-22 |
| Unknown | Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer High Grade Serous Carcinoma, Ovarian Cancer, Exosomes | — | 2018-11-10 |
| Unknown | A Genomic Analysis of Evolution of Epithelia Ovarian Tumors Epithelial Ovarian Cancer, Epithelial Ovarian Tumor of Borderline Malignancy, Driving Mutations | — | 2018-11-10 |
| Unknown | MSI in Circulatory DNA of Endometrial Cancer Microsatellite Instability, Lynch Syndrome, Endometrial Cancer | — | 2018-11-10 |
| Unknown | Long-acting G-CSF for Febrile Neutropenia Epithelial Ovarian Cancer, Colony Stimulating Factors, Febrile Neutropenia | Phase 3 | 2018-11-10 |
| Unknown | A Multi-omics Study of Adenomyosis Adenomyosis, Endometriosis, Ectopic Endometrium | — | 2018-11-10 |
| Unknown | Functional Training for the Prevention of Deep Venous Thrombosis Ankle Motion, Gynecologic Neoplasm, Deep Venous Thrombosis | Phase 3 | 2018-11-10 |
| Unknown | A Multi-omics Study of Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Tumor Invasiveness, Whole Exome Sequencing | — | 2018-11-10 |
| Unknown | Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer Uterine Cervical Neoplasms, Laparotomy, Laparoscopy | — | 2018-11-10 |
| Unknown | HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma Cervical Adenocarcinoma, Human Papillomavirus, Genome-wide Association Study | — | 2018-11-10 |
| Unknown | Pelvic Microbiomes of Benign and Malignant Ovarian Diseases Microbiota, Ovarian Neoplasms, Ribosome Alteration | — | 2018-01-01 |
| Unknown | Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms | — | 2017-09-01 |
| Unknown | Risk-Reducing Surgeries for Hereditary Ovarian Cancer Hereditary Breast and Ovarian Cancer Syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Ovariectomy | N/A | 2017-09-01 |
| Unknown | Survival Outcomes of Uterine Malignancies in Chinese Population Endometrial Neoplasms, Survival | — | 2017-09-01 |
| Unknown | Survival Outcomes of Ovarian Malignancies in Chinese Population Ovarian Neoplasms, Survival | — | 2017-01-01 |
| Unknown | Survival Outcomes of Uterine Cervical Malignancies in Chinese Population Uterine Cervical Neoplasms, Survival | — | 2017-01-01 |